3171 results for «3261»

Filter By

3171 results

Updates on percutaneous treatment of pulmonary embolism

22 May 2025 – From EuroPCR 2025

Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.

Updates on percutaneous treatment of pulmonary embolism

Percutaneous aortic interventions: mastering the complexity

22 May 2025 – From EuroPCR 2025

Master complex percutaneous aortic interventions in this detailed session. Topics include managing life-threatening complications, percutaneous repair of ascending aortic graft pseudoaneurysms, aortic stenting for total occlusions, and troubleshooting endovascular aortic repair failures, providing a comprehensive overview of challenging aortic cases.

Percutaneous aortic interventions: mastering the complexity

Troubleshooting and management communication in LAA closure

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.

Troubleshooting and management communication in LAA closure

Clinical impact of mechanical circulatory support

22 May 2025 – From EuroPCR 2025

Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...

Clinical impact of mechanical circulatory support

Management of bifurcation treatment in high-risk patients

22 May 2025 – From EuroPCR 2025

Explore advanced management strategies for bifurcation treatment in high-risk patients. This session presents techniques including circulatory-supported polymer-free angioplasty, management of spontaneous aorto-coronary dissection-induced cardiac arrest, and innovative reverse controlled balloon-crush methods, supported by challenging case studies.

Management of bifurcation treatment in high-risk patients

ACS management: when imaging matters

22 May 2025 – From EuroPCR 2025

This session focuses on the critical role of intracoronary imaging in acute coronary syndrome (ACS) management. Topics include spontaneous coronary artery dissection (SCAD) cases, the utilization of IVUS and cardiac CT in emergent PCI during cardiogenic shock, and the assessment of non-culprit lesions using OCT to...

ACS management: when imaging matters

Acute complications during distal left main PCI - Part 2

22 May 2025 – From EuroPCR 2025

This session focuses on acute complications encountered during distal left main PCI. Review real-world challenging cases involving multiple unexpected complications, device retrieval techniques, fractured rota burr management during rota-tripsy, and strategies to navigate complex procedural challenges.

Acute complications during distal left main PCI - Part 2

Antiplatelet strategies for clinical dilemmas

22 May 2025 – From EuroPCR 2025

Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...

Antiplatelet strategies for clinical dilemmas

Best companions's case on complications in calcified lesions: episode 2

22 May 2025 – From EuroPCR 2025

Join this session examining complex complications in calcified lesion interventions. Learn from cases featuring controversial approaches that successfully resolved issues, coronary perforation management, retrograde iatrogenic dissection after lithotripsy, and algorithmic bailout strategies essential for navigating challenging calcified lesion complications.

Best companions's case on complications in calcified lesions: episode 2

Managing TAVI-embolisation device

22 May 2025 – From EuroPCR 2025

Focus on managing TAVI device embolization in this specialized session. Discuss detailed techniques such as TAVI-in-TAVI procedures, addressing valve dysfunction, and innovative balloon-assisted retrieval methods for migrated transcatheter heart valves, emphasizing procedural nuances and bailout strategies.

Managing TAVI-embolisation device

Artificial intelligence in the cathlab

22 May 2025 – From EuroPCR 2025

Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.

Artificial intelligence in the cathlab

TAVI coronary access

22 May 2025 – From EuroPCR 2025

Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...

TAVI coronary access

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

22 May 2025 – From EuroPCR 2025

Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

Calcified coronaries: novel devices and techniques

22 May 2025 – From EuroPCR 2025

Gain expert insights into managing calcified coronary lesions with novel devices and techniques. Topics include the safety and efficacy of rotational atherectomy, the distal rail-tracking technique, impact of burr speed and duration, innovative scoring balloon designs, and the RODIN-CUT sequential cutting balloon angioplasty method for moderate-to-severe...

Calcified coronaries: novel devices and techniques

Calcified un-dilatable lesions in ACS: what should I do?

22 May 2025 – From EuroPCR 2025

Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.

Calcified un-dilatable lesions in ACS: what should I do?

CTO beyond the conventional: when new strategies come to the rescue

22 May 2025 – From EuroPCR 2025

Delve into advanced strategies for chronic total occlusion (CTO) beyond conventional methods. This session covers step-by-step re-entry techniques with electrified guidewires, approaches to CTO in small vessels, and indications and methods for occlusion of saphenous vein grafts, illustrated by detailed case discussions and key learnings.

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics
Didn’t find what you were looking for?